S100-Positive Schwann-Cell Tumour
- The GRANULAR CELL TUMOUR is an UNCOMMON, usually BENIGN soft-tissue tumour of SCHWANN-CELL (neural) origin - which is why it is S100-POSITIVE (and SOX10-positive) - composed of cells with characteristic abundant GRANULAR EOSINOPHILIC (lysosome-rich) cytoplasm.
- It typically presents as a SMALL, FIRM, often solitary DERMAL or SUBCUTANEOUS NODULE; the classic site is the TONGUE (and head/neck), but it also arises in the SKIN and SOFT TISSUE of the trunk and limbs, the breast, and (uncommonly) the gastrointestinal tract and other viscera - according to PubMed only a small proportion occur in the gastrointestinal tract.
- HISTOLOGY shows nests or sheets of polygonal cells with abundant granular eosinophilic cytoplasm; immunohistochemistry confirms the neural (Schwann-cell) origin with S100/SOX10 positivity, and the overlying epithelium may show PSEUDOEPITHELIOMATOUS HYPERPLASIA, which can be mistaken for squamous cell carcinoma on a superficial biopsy.
- The vast majority are BENIGN, but a RARE MALIGNANT variant exists and is the dangerous one: features that raise concern include LARGE size (often over about 4-5 cm), RAPID growth, necrosis, increased mitotic activity/pleomorphism and infiltrative margins - malignant granular cell tumours carry a HIGH risk of local recurrence and METASTASIS and significant mortality.
- The DIFFERENTIAL includes other granular/eosinophilic lesions and, because of the pseudoepitheliomatous hyperplasia, squamous cell carcinoma on a small/superficial biopsy - so adequate sampling and S100/SOX10 staining are important to confirm the diagnosis and avoid over-diagnosis of carcinoma.
- MANAGEMENT is COMPLETE surgical EXCISION with CLEAR MARGINS, which is usually curative for benign lesions; SMALL lesions (under about 1 cm) may be monitored in selected cases, but LARGER lesions and any with worrying features warrant WIDE excision, and a MALIGNANT granular cell tumour requires wide resection and surveillance (with consideration of adjuvant therapy) given its high recurrence/mortality.
- “Granular cell tumour = uncommon, usually BENIGN soft-tissue tumour of SCHWANN-CELL (neural) origin -> S100/SOX10 POSITIVE; cells with abundant GRANULAR eosinophilic cytoplasm. Classic site = TONGUE (also skin/soft tissue/limbs, rarely GI).
- “Overlying pseudoepitheliomatous hyperplasia can MIMIC squamous cell carcinoma on a superficial biopsy - confirm with S100/SOX10 and adequate sampling.
- “RARE MALIGNANT variant = the dangerous one: large (often >~4-5 cm), rapid growth, necrosis/mitoses -> high recurrence/metastasis/mortality. Treatment = complete excision with clear margins (wide resection + surveillance for large/malignant).
Small, firm dermal/subcutaneous nodule (classically tongue), S100/SOX10-positive (Schwann-cell origin), with granular eosinophilic cytoplasm - usually benign.
Malignant granular cell tumour - large (often >~4-5 cm), rapid growth, necrosis/mitoses - high recurrence/metastasis. Adequate sampling (pseudoepitheliomatous hyperplasia mimics SCC).
Features, Histology & The Malignant Variant
The granular cell tumour is an uncommon, usually benign soft-tissue tumour of Schwann-cell (neural) origin - hence S100/SOX10-positive - made of cells with abundant granular eosinophilic (lysosome-rich) cytoplasm. It is typically a small, firm dermal/subcutaneous nodule, classically of the tongue but also the skin/soft tissue of the trunk and limbs and (uncommonly) the viscera. Overlying pseudoepitheliomatous hyperplasia can mimic squamous cell carcinoma on a superficial biopsy. A rare malignant variant - large (often over ~4-5 cm), rapidly growing, with necrosis, increased mitoses/pleomorphism - carries a high risk of recurrence, metastasis and mortality and is the one to identify.
| Feature | Benign (the majority) | Malignant (rare) |
|---|---|---|
| Size | Usually small (often under 2 cm) | Often large (over ~4-5 cm) |
| Growth | Slow | Rapid |
| Histology | Bland granular cells | Necrosis, increased mitoses, pleomorphism, infiltration |
| Behaviour | Cured by complete excision | High recurrence/metastasis; significant mortality |
| Treatment | Complete excision (clear margins) | Wide resection + surveillance (+/- adjuvant) |
Management
- Diagnosis: adequate biopsy with S100/SOX10 staining (confirm neural origin; avoid over-diagnosing squamous cell carcinoma from pseudoepitheliomatous hyperplasia).
- Treatment (benign): complete surgical excision with clear margins - usually curative; very small lesions may be monitored in selected cases.
- Large/worrying or malignant lesions: wide resection with clear margins; surveillance (and consideration of adjuvant therapy) given the high recurrence/metastasis risk of the malignant variant.
- Setting: larger/malignant lesions managed at a specialist sarcoma centre.
Although most granular cell tumours are benign, S100-positive Schwann-cell tumours cured by complete excision, two cautions matter. First, the rare malignant variant is genuinely dangerous, carrying a high risk of local recurrence, metastasis and death; the features that should raise concern are a large size (often over about four to five centimetres), rapid growth, necrosis, increased mitotic activity and pleomorphism, and infiltrative margins - so size and growth rate are practical red flags that change the lesion from a simple local excision to a wide resection with surveillance. Second, the epithelium overlying a cutaneous or mucosal granular cell tumour frequently shows pseudoepitheliomatous hyperplasia, which can be mistaken for squamous cell carcinoma on a small or superficial biopsy and lead to over-treatment; adequate sampling and S100/SOX10 confirmation of the neural granular cell tumour prevent this error. Management is therefore complete excision with clear margins, with wide resection and specialist (sarcoma-centre) care for large or malignant lesions.
Evidence & Key Studies
Malignant granular cell tumour - a rare case and review of the literature
- Granular cell tumours are rare, mostly benign soft-tissue neoplasms; only a small proportion (about 8%) occur in the gastrointestinal tract, and the diagnosis is confirmed by S100-positive staining (reflecting the Schwann-cell/neural origin).
- Although rare in some sites, malignant granular cell tumours carry a high risk of mortality and recurrence.
- Small lesions (under about 1 cm) can be monitored, but larger or malignant ones require surgical resection - the case underscores early detection and intervention to prevent severe outcomes.
According to PubMed, the nature of granular cell tumours (rare, mostly benign soft-tissue neoplasms confirmed by S100 positivity, with only a small proportion in the gastrointestinal tract), the high recurrence/mortality risk of the malignant variant, and the management principle (monitor small lesions, resect larger/malignant ones) come from the cited Usman report. The Schwann-cell (neural) origin with S100/SOX10 positivity, the granular eosinophilic cytology, the classic tongue/skin/soft-tissue sites, the pseudoepitheliomatous-hyperplasia mimic of squamous cell carcinoma, and the malignancy criteria (large size, rapid growth, necrosis, mitoses) with complete/wide excision are standard, well-established teaching. (See also our Schwannoma/Neural Tumours, Soft-Tissue Sarcoma Principles and Cutaneous Tumours topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A firm subcutaneous nodule is reported as a granular cell tumour. What is its origin, and how do you decide management?”
Mnemonics & Memory Aids
GRANULAR
Hook:GRANULAR: Granular cytoplasm, S100 (neuRal), Anywhere (tongue), Nodule, Usually benign (PEH mimics SCC), Large=maLignant, Adequate margins, Recurrence with malignant.
What it is
- Uncommon, usually benign soft-tissue tumour of Schwann-cell (neural) origin
- S100/SOX10-positive; granular eosinophilic cytoplasm
- Classic site: tongue (also skin/soft tissue/limbs; rarely GI tract)
Diagnostic pitfall
- Overlying pseudoepitheliomatous hyperplasia mimics squamous cell carcinoma
- Confirm with S100/SOX10 and adequate sampling
- Avoid over-treatment as carcinoma
Malignant variant (rare)
- Large (often over ~4-5 cm), rapid growth
- Necrosis, increased mitoses, pleomorphism, infiltration
- High risk of recurrence, metastasis and mortality
Management
- Complete surgical excision with clear margins (curative for benign)
- Very small lesions may be monitored in selected cases
- Large/malignant: wide resection + surveillance; specialist centre